Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't know what's going on...
But...I LIKE IT!!! A two day rally without news???
Good News must be coming SOON...Go CTC! It's nice to see +4.00 again...
GLTA,
Here are my favorites FWIW:
I'm in: SWME BIPH APYM CPTC BGC YHOO GOOG
Watching: CCHI FONR CYTR XTRN
BIPH was mentioned in my otcstockexchange.com newsletter this morning on their "Stock Watch Alert". I also think a very large boosh may be just around the corner for this one...
APYM has a good looking chart for a breakout soon (or not)...
This one could be Huge! Credit Card transaction processing for the Chinese... 'Nuff said about it...
I have a real good feeling about SWME, good management, low debt, no share dilution in the near future. They have a great product that really works (I use it..) and they have major expansion into the USA just beginning.
CPTC is without a doubt my favorite. News should be coming from them in the next two weeks...It could be China news, you better be in...If there is no good news before the Shareholder Meeting March 1, BAIL OUT!!! This rocket is going to do a round trip and crash and burn...
Happy Hunting,
BIPH Attempting To Breakout!?!?!
Somebody give it a good SHOVE above 1.40...
It already has double the average 10 day volume, with three hours to go...BOOSH!!!
The chart is improving for the first time
in quite a while. A nice double bottom finally broke up and took out Thursdays and Fridays intraday high. That's the first bull signal in a long time. I agree, a 60% retracement from the all time highs is enough.
3.26 "might" be the bottom for a while. It only took 100K shares traded today to move up .20 It looks like the buyers are back...(for the time being).
GLTA,
Just listened to BIPH CEO Interview:
And I am even more encouraged with this little gem.
Added some more at the open today, and plan to add a lot more the day it closes above 1.45
EP had some very good things to say this morning:
http://www.investorshub.com/boards/read_msg.asp?message_id=5428933
Good Luck to All Longs!
Swiss Medica Provides Revenue Guidance for 2005
Monday February 14, 9:03 am ET
TORONTO--(BUSINESS WIRE)--Feb. 14, 2005--Swiss Medica Inc. (OTCBB:SWME - News) -
"We now have sufficient data, based upon recent sales of the O24 Essential Oil Pain Neutralizer in the U.S. and Canada, that we can present guidance for FY2005," announced Chief Executive Officer, Raghu Kilambi. "For the twelve-month period, ending 31 December 2005, Swiss Medica expects organic net revenues for the Company's Flagship O24 Essential Oil Pain Neutralizer, to be between US$12 and US$14 million. We also expect to report positive EBITDA in the fourth quarter of 2005."
"We are delighted with the exponential sales growth anticipated during 2005," said Mr. Kilambi. "Swiss Medica has found a loyal customer base, which prefers the O24 Essential Oil Pain Neutralizer over competitive external and internal pain relief products. Concrete evidence describes a broad acceptance of the O24 pain reliever by some of North America's largest retailers, and confirms an ongoing success story for our US-patented all natural product.
Swiss Medica defines EBITDA as earnings before interest, taxes, depreciation, amortization, and with other non-cash charges. EBITDA is expected to turn positive in the fourth quarter of 2005 as Swiss Medica continues to aggressively re-invest in the proven marketing strategies, which brought about the instantaneous acceptance of, and rapid sales growth for, the O24 pain relief product.
"We will continue to rely upon the dependable marketing and PR strategies, which are now building the popular O24 brand," said Mr. Kilambi. "Our revenue projections do not include the launch of related pain relief products, or any acquisitions, during this twelve-month period. We expect to provide additional guidance, after we review the results of our multi-media campaign which commences in the very near future."
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
GLTA,
Swiss Medica Provides Revenue Guidance for 2005
Monday February 14, 9:03 am ET
TORONTO--(BUSINESS WIRE)--Feb. 14, 2005--Swiss Medica Inc. (OTCBB:SWME - News) -
"We now have sufficient data, based upon recent sales of the O24 Essential Oil Pain Neutralizer in the U.S. and Canada, that we can present guidance for FY2005," announced Chief Executive Officer, Raghu Kilambi. "For the twelve-month period, ending 31 December 2005, Swiss Medica expects organic net revenues for the Company's Flagship O24 Essential Oil Pain Neutralizer, to be between US$12 and US$14 million. We also expect to report positive EBITDA in the fourth quarter of 2005."
"We are delighted with the exponential sales growth anticipated during 2005," said Mr. Kilambi. "Swiss Medica has found a loyal customer base, which prefers the O24 Essential Oil Pain Neutralizer over competitive external and internal pain relief products. Concrete evidence describes a broad acceptance of the O24 pain reliever by some of North America's largest retailers, and confirms an ongoing success story for our US-patented all natural product.
Swiss Medica defines EBITDA as earnings before interest, taxes, depreciation, amortization, and with other non-cash charges. EBITDA is expected to turn positive in the fourth quarter of 2005 as Swiss Medica continues to aggressively re-invest in the proven marketing strategies, which brought about the instantaneous acceptance of, and rapid sales growth for, the O24 pain relief product.
"We will continue to rely upon the dependable marketing and PR strategies, which are now building the popular O24 brand," said Mr. Kilambi. "Our revenue projections do not include the launch of related pain relief products, or any acquisitions, during this twelve-month period. We expect to provide additional guidance, after we review the results of our multi-media campaign which commences in the very near future."
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
BIPH--Interview With The CEO:
Biophan CEO Discusses Company's Technology Portfolio and Business Strategy in Interview with WallSt.Net, Available Online
Monday February 14, 6:00 am ET
Company Chief Reports on Progress in Licensing Proprietary Technology for New Generation of Biomedical Products
ROCHESTER, N.Y.--(BUSINESS WIRE)--Feb. 14, 2005-- Biophan Technologies, Inc. (OTCBB: BIPH - News), a developer of next-generation biomedical technology, has announced the availability of an audio interview given by Company CEO, Michael Weiner, to online investor information service WallSt.net.
In the interview, Mr. Weiner described the scope of Biophan's expanding intellectual property portfolio in nanotechnology and other areas that are enabling the development of new biomedical products that can solve critical issues in healthcare. He discussed the Company's product and technology development agreements with leading medical instrument makers such as Boston Scientific, and outlined Biophan's strategy to drive substantial revenue growth through licensing of its proprietary solutions to makers of products for the healthcare and life sciences marketplace.
The ten-minute streaming audio interview can be accessed at http://www.WallSt.net/. To listen, click on the BIPH ticker symbol on the left hand column of the page or enter the BIPH symbol in the Audio Search window. Registration to listen to the interview is free.
Among the specific market sectors areas Mr. Weiner discussed are Biophan's leadership in development of proprietary solutions to allow implanted medical devices, such as pacemakers, to be used safely in Magnetic Resonance Imaging (MRI) environments. The Company has also solved a range of problems that have traditionally prevented other implanted medical devices from being clearly and effectively imaged under MRI.
In addition, Mr. Weiner elaborated on the value of Biophan's planned acquisition of AMRIS, a leading German-based developer of MRI-safe and image-compatible technology solutions and biomedical devices. The planned acquisition will significantly expand Biophan's existing international intellectual property portfolio, granting the Company exclusive license to fifteen issued and pending patents, covering imaging of devices such as stents and other vascular implants. Biophan currently holds a total of 104 U.S. patents, licenses, or applications.
GLTA,
You are welcome aliens vs. gerbils...
Though APYM is questionable at the moment...
It set up a small "W" today I thought would break up.
It just dumped Hard... From 1.63 to 1.48 in 20 minutes...Bummer!!!
BIPH Booshed this morning!!!...EOM
Rattman--If we go below 3.22(The low set on Jan. 25th)
That breaks a major support level and sends us down to who knows where at this point... It won't be a good thing to go below 3.22 That would be a sell signal for many...
I find the action at ThomsonFN in the last month a bit confusing...Large buying interest all the way down, no sells.
Can this be considered Accumulation???
http://iw.thomsonfn.com/iwatch/cgi-bin/iw_ticker?t=CPTC&range=30&mgp=0&i=3&hdate=&am...
Just a hunch, but I feel "maybe" a big PR Monday at 8AM?
GLTA,
3.22 MUST HOLD!!! EOM
YES!!!GO APYM!!!!!!!!!!!!!!!!!EOM
CCHI Looks like it could boosh today EOM
Yesterdays action after the Good PR:
Is a little disturbing...I thought for sure we would get a boosh out of it? Oh well, I'm still in until we breakdown thru .32
GLTA,
BIPH--Todays NEWS:
Biophan Noted in BusinessWeek Report on Nanotechnology Science and Marketplace
Friday February 11, 6:00 am ET
Company Named Among Key Players in Healthcare Sector
ROCHESTER, N.Y.--(BUSINESS WIRE)--Feb. 11, 2005--Biophan Technologies, Inc. (OTCBB: BIPH - News), a developer of next-generation biomedical technology, has announced that the Company has been included in BusinessWeek magazine's (February 14, 2005 issue, page 67) cover story about the latest innovations in nanotechnology, the multi-billion-dollar marketplaces nanoscience currently enable, and the potential for significant further growth.
The BusinessWeek cover story, entitled "The Business of Nanotech," describes the progression of nanotechnology from the laboratories to a burgeoning marketplace involving key industries, including healthcare, automotive, energy, computers and semiconductors, advanced consumer materials, and many others.
In the BusinessWeek article, Biophan is listed as one of seven nanotechnology players in the healthcare sector along with General Electric, Johnson & Johnson, NASA, and others.
The article quotes nanotechnology market researchers who project the 2005 nanotechnology marketplace will reach an estimated $13 billion. By the end of the decade, however, the nanotechnology market will grow to an estimated $292 billion, according to the industry observers.
"The BusinessWeek article does an excellent job of describing the scope and potential of the nanotechnology marketplace and the position of technology leaders such as Biophan in enabling the nanotechnology revolution," said Michael Weiner, Biophan CEO. "The article conveys the financial and investment potential that nanotechnology presents in healthcare and medical science, where Biophan holds key proprietary technologies."
NEWS: Biophan Technologies, Inc.
Biophan Noted in BusinessWeek Report on Nanotechnology Science and Marketplace
Friday February 11, 6:00 am ET
Company Named Among Key Players in Healthcare Sector
ROCHESTER, N.Y.--(BUSINESS WIRE)--Feb. 11, 2005--Biophan Technologies, Inc. (OTCBB: BIPH - News), a developer of next-generation biomedical technology, has announced that the Company has been included in BusinessWeek magazine's (February 14, 2005 issue, page 67) cover story about the latest innovations in nanotechnology, the multi-billion-dollar marketplaces nanoscience currently enable, and the potential for significant further growth.
The BusinessWeek cover story, entitled "The Business of Nanotech," describes the progression of nanotechnology from the laboratories to a burgeoning marketplace involving key industries, including healthcare, automotive, energy, computers and semiconductors, advanced consumer materials, and many others.
In the BusinessWeek article, Biophan is listed as one of seven nanotechnology players in the healthcare sector along with General Electric, Johnson & Johnson, NASA, and others.
The article quotes nanotechnology market researchers who project the 2005 nanotechnology marketplace will reach an estimated $13 billion. By the end of the decade, however, the nanotechnology market will grow to an estimated $292 billion, according to the industry observers.
"The BusinessWeek article does an excellent job of describing the scope and potential of the nanotechnology marketplace and the position of technology leaders such as Biophan in enabling the nanotechnology revolution," said Michael Weiner, Biophan CEO. "The article conveys the financial and investment potential that nanotechnology presents in healthcare and medical science, where Biophan holds key proprietary technologies."
APYM Has Good PR Today...
Let us Boosh!!!
Asia Pay Gains License Approval from Shenzhen Government
Friday February 11, 7:50 am ET
SEATTLE, and HONG KONG, Feb. 11 /PRNewswire-FirstCall/ -- Asia Payment Systems, Inc. (OTC Bulletin Board: APYM - News) announced today that the Shenzhen Municipal Government has approved a Representative Office License for Asia Payment Systems.
Asia Pay is a credit card processing services company that provides a growing network of credit card clearing services to merchants and financial institutions in China and other markets. The primary focus of Asia Pay's business development efforts is the rapidly growing Chinese credit card market. Asia Pay aims to become a leading China-wide provider of world-class third-party processing services to bankcard-accepting merchants and card issuers.
Matt Mecke, President & CEO of Asia Pay, announced, "We are very pleased to be able to announce today the approval of our Representative Office License by the Shenzhen Municipal Government. We feel this approval is an important step in Asia Pay's becoming the premier payment services company in China. We continue to cooperate with our China partners and related parties to develop China-wide processing systems and related applications and services. This Shenzhen Representative Office approval advances Asia Pay's plans to provide leading-edge payment processing applications and services to our customers in China and throughout the region. We are pleased to be part of the dynamic economic growth and modernization for which Shenzhen is known worldwide."
Shenzhen is one of the most prosperous and modern cities in China. Shenzhen became China's first Special Economic Zone (SEZ) in 1980. In the past 25 years, Shenzhen has grown from a small border town to a modern manufacturing center and international port, with a permanent resident population of approximately 5 million. The city's GDP per capita reached US$5,604 in 2002, making Shenzhen one of the most prosperous cities in China. According to Shenzhen Government Online (http://www.sz.gov.cn), the city is ranked fourth in GDP, third in revenue among China's large and medium-sized cities, second in container-handling capacity, and first for seven consecutive years in China's import and export volumes.
About Asia Payment Systems, Inc. (http://www.asia-pay.com)
NEWS: Let's hope we get a boosh from this:
Asia Pay Gains License Approval from Shenzhen Government
Friday February 11, 7:50 am ET
SEATTLE, and HONG KONG, Feb. 11 /PRNewswire-FirstCall/ -- Asia Payment Systems, Inc. (OTC Bulletin Board: APYM - News) announced today that the Shenzhen Municipal Government has approved a Representative Office License for Asia Payment Systems.
Asia Pay is a credit card processing services company that provides a growing network of credit card clearing services to merchants and financial institutions in China and other markets. The primary focus of Asia Pay's business development efforts is the rapidly growing Chinese credit card market. Asia Pay aims to become a leading China-wide provider of world-class third-party processing services to bankcard-accepting merchants and card issuers.
Matt Mecke, President & CEO of Asia Pay, announced, "We are very pleased to be able to announce today the approval of our Representative Office License by the Shenzhen Municipal Government. We feel this approval is an important step in Asia Pay's becoming the premier payment services company in China. We continue to cooperate with our China partners and related parties to develop China-wide processing systems and related applications and services. This Shenzhen Representative Office approval advances Asia Pay's plans to provide leading-edge payment processing applications and services to our customers in China and throughout the region. We are pleased to be part of the dynamic economic growth and modernization for which Shenzhen is known worldwide."
Shenzhen is one of the most prosperous and modern cities in China. Shenzhen became China's first Special Economic Zone (SEZ) in 1980. In the past 25 years, Shenzhen has grown from a small border town to a modern manufacturing center and international port, with a permanent resident population of approximately 5 million. The city's GDP per capita reached US$5,604 in 2002, making Shenzhen one of the most prosperous cities in China. According to Shenzhen Government Online (http://www.sz.gov.cn), the city is ranked fourth in GDP, third in revenue among China's large and medium-sized cities, second in container-handling capacity, and first for seven consecutive years in China's import and export volumes.
About Asia Payment Systems, Inc. (http://www.asia-pay.com)
Todays descending triangle just brokedown...
Get ready for a little dumpskie...
Thanks Gina! for 3 excellent posts here today...
We appreciate you showing up over here and sharing your little gems of knowledge. Keep up the good work.
Musk
CCHI is breaking to the Upside today...
Against all of my expectations. Already above the 10 day average volume (345,751) in the first 45 minutes!
APYM is failing to boosh, against most opinions I've heard, including mine. Dumping hard instead...
CPTC opened down .10, immediatly took out yesterdays low. Buckle up for another dump...
SWME got a good PR today, and is stalling .02 above a breakdown of it's chart (a one and a half month head and shoulders).
Anything Good happening out there today?
Thanks oris52--That's very good news...
As we collectively breath a sigh of relief.
A Good PR couldn't have come at a better time. Maybe we'll have a nice boost up today, and won't breakdown through .32
Bellwether Report Believes Galton Biometrics (OTC:GALB)
Is Poised for Significant Move!
Hello Members,
We wanted to take some time to re-introduce one the most lucrative opportunities our analysts have discovered, as the company seems once again poised for another spectacular breakout.
It looks as though Galton Biometrics (OTC:GALB) is making a steady climb, and seems to be generating a lot of positive feedback from investors. We believe that this could be in speculation of solid corporate developments or perhaps contracts. In our opinion at their current valuation of below $2.00, this could very easily turn into a profitable opportunity for the BWR members.
For those of you not familiar with Galton Biometrics, they are a company that has provided several unique developments in the area of biometric fingerprint technology that enable fast individual authentication, precise identification searches, as well as cross-platform data interoperability. Their software solution is a highly accurate method of generating a short, universal, numeric identifier based on a person’s fingerprint. This encrypted Biometric Identifier Number (BIN) can be used with personal credentials such as passports, Visa’s, and ID cards such as Bank Cards, Drivers Licenses, Health Cards, etc., for one-to-one guaranteed authentication. Galton is the distributor of this innovate technology in Europe and owns the IP rights in the UAE.
There is more information available on this small-cap homeland security gem at www.galtonbiometrics.com
Thank You
Jay Lee
CEO Bellwether Report
Bellwether Report Believes Galton Biometrics (OTC:GALB)
Is Poised for Significant Move!
Hello Members,
We wanted to take some time to re-introduce one the most lucrative opportunities our analysts have discovered, as the company seems once again poised for another spectacular breakout.
It looks as though Galton Biometrics (OTC:GALB) is making a steady climb, and seems to be generating a lot of positive feedback from investors. We believe that this could be in speculation of solid corporate developments or perhaps contracts. In our opinion at their current valuation of below $2.00, this could very easily turn into a profitable opportunity for the BWR members.
For those of you not familiar with Galton Biometrics, they are a company that has provided several unique developments in the area of biometric fingerprint technology that enable fast individual authentication, precise identification searches, as well as cross-platform data interoperability. Their software solution is a highly accurate method of generating a short, universal, numeric identifier based on a person’s fingerprint. This encrypted Biometric Identifier Number (BIN) can be used with personal credentials such as passports, Visa’s, and ID cards such as Bank Cards, Drivers Licenses, Health Cards, etc., for one-to-one guaranteed authentication. Galton is the distributor of this innovate technology in Europe and owns the IP rights in the UAE.
There is more information available on this small-cap homeland security gem at www.galtonbiometrics.com
Thank You
Jay Lee
CEO Bellwether Report
I hear you oris52...
I got my parachute on at .315, and I'm definitly bailing out there...very dissapointing action the last 3 days.
The chart is forming a huge head and shoulders, and if .32 is taken out, it will go to around .20
I got in because I saw an ascending triangle that formed last week, and was just hoping it would break up...
I knew very well this head and shoulders could finish forming, and it looks like it is...
Sometimes one just "has to" take a chance...
The best scenario for this chart is for us to stay above .32 and below .41 for a while and consolodate in this uptrend, this could form a symetrical triangle in an uptrend, sometimes a very bullish chart pattern.
I like this security, no debt, no dilution forseen, a proven product that is in the marketplace and performing well, with plans of major expansion. I went online and ordered some 024 the other day. I hope it works good--getting old 'ya know?
These folks like fluffy PR's--we could use one of those (or a meaty one!) this week to give the pps a boost.
GLTA!
Thanks for the boosh warning EP--
I jumped in today just under 1.50
This one could be another Zip Code Changer...
Let 'er Rip!!!
GLTA,
Bottomed Yet???
SWME is on the SHO list:
http://www.nasdaqtrader.com/aspx/regsho.aspx
Maybe we'll see a short covering rally here soon.
This could have something to do with the depressed pps, they're trying to cover their shorts at the best possible price...
APYM Dumped first thing, but now is:
BOOSHING!!!
Update to message: Never mind, dumping again...
What a wild day for APYM!!!
It's got double the average daily volume already today...
Willy--Chart could be at a pivot point, though I doubt it is, as the only thing that's going to pivot us up is a GOOD PR!!! Yesterdays fluffy one was probably "necessary" as part of the CTC/GC contract agreement...
Yesterdays surge up could have been just a deadcat bounce for the fall from 4.63 to 3.46 We fell 1.23, and bounced .53--an almost 50% deadcat bounce--not bad. We went from totally oversold the first half hour., to totally overbought in one session on the 10 day/hourly chart. So, we should see a pullback here...If we can stay above 3.71 and rally from there the chart still looks somewhat OK. If we close above 4.15, I'm actually bullish again. If we break below 3.71, I'd be putting my hard hat on again, as 3.46 will be tested. If that test fails, 3.22(The Big One) next, and if that fails I'll be loading up at around 2.80--2.90
This is still a very UGLY! chart...Scary describes it well also...The chart I posted yesterday was the best looking time frame I could find. The longer term charts are looking real weak.
I predict if we don't close above 4.00 soon(this week) on decent volume (and that's not going to happen today, as we have only 33K this first hour), it's time to buckle up for another bumpy ride...
BTW, I have to admit I'm feeling a little like a dumba**, as I haven't sold a single share yet, and I sit here every day watching my profits dissappear into thin air, but believe it or not, I'm not selling EVER!!! This rocket may have had the countdown delayed, but it's a "guarantee"(IMO) that liftoff will (sooner or later) occur...
GLTA,
APYM, SWME, CPTC All on top 25 OTC-BB Volume Leaders List for yesterday:
http://www2.barchart.com/otcvl.asp
APYM--Buy signals in all time frames. I've never any stock (except CPTC) on this page at 100% Buy...Solid Green....
http://quote.barchart.com/texpert.asp?sym=APYM&code=BSTK
APYM is looking especially tasty today, it might be worth a play...
CCHI--Top Heavy Indeed...
Too Vertical a Liftoff--Unstable...
Double bottom yielded up all it should have--3 lines.
Very Overbought for days now...Expect a pullback to just under .90
If Stochastics drop to 50 (a pps of about .87) and rally from there, that's a nice ascending triangle for that indicator, and should signal another uptrend.
Rattman--The Charts Say:
Biggest Volume in 11 days, this could be the bottom, as the nine day head and shoulders yielded down about all it should have...
The last two days form an inverse head and shoulders, with a breakout up above 3.99 I'm hoping for a close above 4.00 today.
The 20SMA just crossed up over the 50SMA--that's the first buy signal since Jan. 31
Very bullish to get above 4.15, the 200SMA, and to find support at the 50 line of Stochastics is also bullish. If the Stochastics go below 50 now, we'll double top below 4.00, and we'll see a test of todays low.
GLTA,
gold--I asked Mr. Carswell about a tour during the SH Meeting on Friday, and he said "No"...
I think everyone of us that is going, and would like a tour, should email him ASAP and request that it be arranged.
If he was flooded with emails requesting a tour, I would hope that he would find a way to arrange it...
I think we should start a petition drive on both boards to get this accomplished.
I for one, will be dissappointed if I fly all the way out there, and am denied access to the HQ. That is one of the main reasons I planned to go to Irvine March 1. In fact, I may not attend this year if a tour of their facility cannot be arranged...Next years SH Meeting should be a lot more interesting anyway IMO. This rocket should have taken off by then, and the mood of all will be much higher...
Interesting Volume Action Today:
In the first 20 minutes we fell .39 on 280K.
It only took 480K and four hours to move us up .53 off todays low, to set a new intraday high +.14 I'd bet we close above 4.00 today...
It seems like there was more meat on that bone they threw us this morning than origanlly thought. I guess any news that brings even only a few new potential investors our story, could be considered "good news". It's apparent the buyers are back, at least for the moment...
The daily volume has been picking up from around 200K/day for the last 10 days, to over 700K/day in the last two days. Todays volume will beat yesterdays. http://table.finance.yahoo.com/k?s=cptc.ob&g=d
With any luck, this is the bottom. I thought the 9 day head and shoulders would dump to the low 3.30's So... maybe we start up from 3.46 instead
Fluff PR--Old News--How Sad--Going Down!
It's sad the countdown to the NAS is over and has to begin again...
I was hoping for a PR today to stop this slide we're in. Oh well...Looks like we go test 3.22
I'm running out of Patience about news. I need some more Patience, and I need it NOW!
I sure hope we don't need to go back under 3.00. The only thing that's going to keep that from happening is News Soon! With all the irons they have in the fire, you'd think they could throw us a bone once in a while...
China may still be happening, but it seems like we're digging our way there instead of flying....
(Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)
CYTR is on the SHO List:
http://www.nasdaqtrader.com/aspx/regsho.aspx
Maybe we'll get a short squeeze next week ;>)
Just spoke with James Carswell:
About three things--
(1) What papers do we need to gain entry to the SH Meeting.
A valid government issue I.D., and a Proxy Statement. I got a strong impression he would let you in even without a Proxy Statement. I asked because my broker sent us an email Proxy, and won't get a hard copy unless I request it. He said to print my online Proxy form and bring it with us.
I asked about voting our shares in person at the Meeting, he told me "only one person voted his shares in person at the last
SH Meeting." Apparently everyone else voted online. Interesting....
(2) No, they have no plans for any tours of their Headquarters around the time of the SH Meeting (Bummer...), though he did say they can be arranged at other times of the year for small groups, or individuals, if his schedule permits.
(3) I mentioned that we are members of the IHUB and RB message boards for CPTC, and I hinted that the "natives were getting restless" about the China deal, and asked directly "Is the China deal still ON???" His answer was "YES"!!! At that, I said Thank You Very Much, and Goodbye. (I didn't bother asking him when news would be coming out on this subject, or any other, because I knew he wasn't going to tell me...)
The good news is: China is still ON!
The bad news is: No tours of CTC HQ during the SH Meeting.
I feel better after talking to Mr. Carswell for the first time. He seems like a good guy. He returned our call in less than an hour.
Have a good weekend y'all, Hopefully we'll have a good week next week...